Pengaruh Penggunaan Terapi Adjuvant Terhadap Kesembuhan Pasien Covid 19 : Studi Literature
DOI:
https://doi.org/10.55123/insologi.v1i3.326Keywords:
Covid-19, adjuvant therapyAbstract
Adjuvant therapy is now a trend issue in the world and in Indonesia in the face of the COVID-19 pandemic. The purpose of this paper is to examine the literature on the effect of using adjuvant therapy on covid 19 patients. This literature review uses e-database sources: ebscohost, proquest, pubmed, and science direct, where the articles used in 2015-2021 with keywords adjuvant therapy and covid 19. There were 7 articles that met the inclusion criteria. The entire article states that adjuvant therapy provides benefits for healing covid 19 patients. Research that has had a clinical improvement effect on covid 19 patients conducted by Chavarria (2020) uses antioxidants and pentoxifylline. Shohan et al, (2021) used quercetin in combination with antiviral drugs. Castillo et al, (2020) use melatonin. Trejo et al, (2021) used hydrogen peroxide. Luo et al, (2020) use of traditional Chinese medicine. Jamali MoghadamSiah et al, (2021) used high doses of vitamin C and Hiedra et al (2020) used intravenous vitamin C. The key to adjuvant therapy is vitamin C, Chinese medicine, hydrogen peroxide, antioxidants and pentoxifylline, melatonin and quercetin, which can be used as adjuvant therapy for healing and clinical improvement in COVID-19 patients.
Downloads
References
Trejo et al. 2021. Hydrogen Peroxide as an Adjuvant Therapy for COVID-19: A Case Series of Patients and Caregivers in the Mexico City Metropolitan Area. https://www.hindawi.com/journals/ecam/2021/5592042/
Kagan D, Gilad JM, & Fire M. 2020. Scientometric Trends for Coronaviruses and Other Emerging Viral Infections. bioRXiv. https://www.biorxiv.org/content/10.1101/2020.03.17.995795v2.full.
Hiedra R et al. 2020. The use of IV vitamin C for patients with COVID-19: a case series. https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1794819
JamaliMoghadamSiah et al. 2021. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. https://eurjmedres.biomedcentral.com/track/pdf/10.1186/s40001-021-00490-1.pdf
Rafie, Barratut Taqiyyah. 2021. Data terkini WHO: Jumlah kasus Covid-19 di seluruh dunia melampaui 90 juta kasus! Sumber Xinhua. https://internasional.kontan.co.id/news/data-terkini-who-jumlah-kasus-covid-19-di-seluruh-dunia-melampaui-90-juta-kasus.
Perhimpunan Rumah Sakit Seluruh Indonesia (PERSI). 2021. Persebaran Kasus Covid-19 – tanggal 29 Januari 2021. https://persi.or.id/persebaran-kasus-covid-19-tanggal-29-januari-2021.
Haq et al. 2021. factors related to the severity of coronavirus disease 2019 (covid-19) infection: a literature review. Vol 9 No 1 (2021): JIMKI : Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.1 Edisi Maret - Juli 2021. https://bapin-ismki.e-journal.id/jimki/article/view/338
Huang C, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext
Tang J.W, Tambyah P.A,. Hui, D.S.C. 2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China. https://www.journalofinfection.com/article/S0163-4453(20)30038-4/fulltext
Habibzadeh, & Stoneman E.K. 2020. The novel coronavirus: a bird's eye view. Int J Occup Environ Med, 11 (2) (2020), pp. 65-71. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3564637
Luo et al. 2020. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China. https://cmjournal.biomedcentral.com/articles/10.1186/s13020-020-00317-x
Feret et al. 2021. Pentoxifylline as a Potential Adjuvant Therapy for COVID-19:
Impeding the Burden of the Cytokine Storm. https://pubmed.ncbi.nlm.nih.gov/34830588/
Chavarria et al. 2021. Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19. https://pubmed.ncbi.nlm.nih.gov/33680348/
Shohan et al, 2021. The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial . https://linkinghub.elsevier.com/retrieve/pii/S0014-2999(21)00771-8
Castillo et al, 2020. Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO): a case series. https://www.melatonin-research.net/index.php/MR/article/view/88.
Harapan et al. 2020. Coronavirus disease 2019 (COVID-19): A literature review. Journal of Infection and Public Health. https://www.sciencedirect.com/science/article/pii/S1876034120304329?via%3Dihub
Singhal T. 2020. A Review of Coronavirus Disease-2019 (COVID-19).https://www.ncbi.nlm.nih.gov/pmc/articles/PMC709072
Piero et al. 2021. Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197660/
N. Arminarahmah, A. D. GS, G. W. Bhawika, M. P. Dewi, and A. Wanto, “Mapping the Spread of Covid-19 in Asia Using Data Mining X-Means Algorithms,” IOP Conf. Series: Materials Science and Engineering, vol. 1071, no. 012018, pp. 1–7, 2021.
N. A. Febriyati, A. D. GS, and A. Wanto, “GRDP Growth Rate Clustering in Surabaya City uses the K- Means Algorithm,” International Journal of Information System & Technology, vol. 3, no. 2, pp. 276–283, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marlin Sutrisna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa INSOLOGI (Jurnal Sains dan Teknologi) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada INSOLOGI (Jurnal Sains dan Teknologi).
